Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

NCT05711719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Coronary Microvascular Dysfunction

Interventions

DRUG: Vericiguat
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]